Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Everest Group enters May with a fresh earnings beat behind it and a cluster of upward analyst revisions pushing targets higher — the stock added 7% over the past month to $349.68, and the Street is still catching…
WMB closed the week at $76.12, up 4.2% over five sessions and 25.5% year-to-date, even as options traders signal the most bullish positioning seen in months. The strongest current in Williams' setup is the breadth and…
WEYS heads into its Q1 2026 earnings call with a sharp weekly decline doing most of the talking — the stock dropped 8.4% to $31.80, raising the question of whether a genuine re-rating is underway or whether the move is…
WDC just posted one of its best weeks in years. The stock jumped 19% in five days to close at $465.26 — a 58% gain over the past month. The real tension this week is not the rally itself, but the fact that short…
WSFS Financial heads into next week's May 14 earnings call with the Street in a notably constructive mood — target prices rising across the board, short interest modest and retreating, and the borrow market wide…
VRTX heads into its Q1 2026 results — scheduled for May 13 — with options traders at their most defensive in months, even as the Street raised price targets and the lending market remains wide open. The clearest signal…
Valley National Bancorp heads into its May 18 earnings call with an awkward split on the Street: a Morgan Stanley downgrade fresh this morning against a chorus of recent upward target revisions from everyone else. The…
VSE Corporation just delivered an earnings beat that reshuffled the deck — and the market's reaction tells a more complicated story than the headline numbers suggest. Q1 adj. EPS came in at $1.17 against an $0.91…
United Therapeutics enters the post-earnings period with an unusual alignment: options traders turned the most bullish they've been all year on the day the CEO and CFO were selling stock at the open. The insider angle…
United Fire Group heads into the week after earnings with a fresh upgrade in hand, short sellers quietly paring back, and options positioning that reads as anything but fearful. The headline story is the analyst…
Unisys Corporation enters the post-earnings window having silenced the bears — at least for now. The company reported Q1 2026 results on May 5, and the headline numbers were better than feared. Adjusted EPS came in at…
UFI heads into the week after its Q3 2026 print with a narrative that has quietly shifted: a company still losing money, but losing less of it than almost anyone expected. The numbers from Tuesday's after-market…
Centrus Energy Corp. enters its May 7 earnings call in a paradoxical position: short sellers have held one of the largest positions in the nuclear fuel space for months, yet those same bears have been quietly trimming…
USANA Health Sciences arrives at its May 20 earnings date with a quietly shifting positioning backdrop — short sellers who were aggressively building in mid-April have been covering steadily, while options traders have…
Twin Disc, Incorporated reported Q3 fiscal 2026 results on May 6 just hours before this note was filed, and the print crystallises a tension that has been building for weeks: the industrial machinery maker is genuinely…
TRMB delivered a clean earnings beat today and raised its full-year outlook — the clearest test yet of whether its software transition is generating durable momentum heading into the summer. Q1 adjusted EPS came in at…
TransAlta reported Q1 2026 results this morning with adjusted EPS of C$0.04 beating the C$0.01 consensus estimate — and the company reaffirmed its full-year guidance. Yet the stock entered the day having fallen 8.3%…
TRI reported Q1 2026 results on May 5 that topped estimates on both revenue and earnings — yet the stock slipped 0.8% the following session, closing at CAD 129.43, even as it held a 3.6% gain on the week. The tension…
Thermo Fisher Scientific heads into its May 20 Q1 results with the stock lagging a sharp sector rebound, the Street trimming targets across the board, and a closely watched earnings history that has punished…
Teva Pharmaceutical Industries enters the week with a rare burst of momentum. A strong Q1 earnings print sent the stock up nearly 11% on April 29 alone. The stock is now up 13% on the week and 19% over the past month,…
